Cytosolic phospholipase A2 mediates neuronal apoptosis induced by soluble oligomers of the amyloid-beta peptide - Wikidata - wikimedia - TriplyDB

Cytosolic phospholipase A2 mediates neuronal apoptosis induced by soluble oligomers of the amyloid-beta peptide

Cytosolic phospholipase A2 mediates neuronal apoptosis induced by soluble oligomers of the amyloid-beta peptide

http://www.wikidata.org/entity/Q28568454

about

Srf1 is a novel regulator of phospholipase D activity and is essential to buffer the toxic effects of C16:0 platelet activating factor Enhanced Phospholipase A2 Group 3 Expression by Oxidative Stress Decreases the Insulin-Degrading Enzyme Phospholipase A2 reduction ameliorates cognitive deficits in a mouse model of Alzheimer's disease Using neurolipidomics to identify phospholipid mediators of synaptic (dys)function in Alzheimer's Disease.Phospholipase d2 ablation ameliorates Alzheimer's disease-linked synaptic dysfunction and cognitive deficits.Nitrous oxide plus isoflurane induces apoptosis and increases beta-amyloid protein levels Omega-3 fatty acids and cognitive function in women.Role of cytosolic phospholipase A2 in oxidative and inflammatory signaling pathways in different cell types in the central nervous system Prolonged exposure of cortical neurons to oligomeric amyloid-β impairs NMDA receptor function via NADPH oxidase-mediated ROS production: protective effect of green tea (-)-epigallocatechin-3-gallate.Phospholipases A2 and neural membrane dynamics: implications for Alzheimer's disease.Cytosolic phospholipase A2 protein as a novel therapeutic target for spinal cord injury Characterization of prefibrillar Tau oligomers in vitro and in Alzheimer disease.Altered neuroinflammatory, arachidonic acid cascade and synaptic markers in postmortem Alzheimer's disease brain Linking lipids to Alzheimer's disease: cholesterol and beyond.Cytosolic phospholipase A₂: physiological function and role in disease.Alterations in Lipid Levels of Mitochondrial Membranes Induced by Amyloid-β: A Protective Role of Melatonin.Integrating cytosolic phospholipase A₂ with oxidative/nitrosative signaling pathways in neurons: a novel therapeutic strategy for AD.A Signaling Lipid Associated with Alzheimer's Disease Promotes Mitochondrial Dysfunction The inhalation anesthetic desflurane induces caspase activation and increases amyloid beta-protein levels under hypoxic conditions Role of the p38 mitogen-activated protein kinase/cytosolic phospholipase A2 signaling pathway in blood-brain barrier disruption after focal cerebral ischemia and reperfusion Denervation induces cytosolic phospholipase A2-mediated fatty acid hydroperoxide generation by muscle mitochondria Botanical phenolics and brain health Cerebral arachidonate cascade in dementia: Alzheimer's disease and vascular dementia Amyloid-beta42 signals tau hyperphosphorylation and compromises neuronal viability by disrupting alkylacylglycerophosphocholine metabolism.Phospholipases A2 and inflammatory responses in the central nervous system.Targeting NADPH oxidase and phospholipases A2 in Alzheimer's disease.Lipid metabolism in Alzheimer's disease Dietary arachidonic acid increases deleterious effects of amyloid-β oligomers on learning abilities and expression of AMPA receptors: putative role of the ACSL4-cPLA2 balance.Minocycline targets multiple secondary injury mechanisms in traumatic spinal cord injury.Phospholipase A2 inhibitors protect against prion and Abeta mediated synapse degeneration.Amyloid β-peptide oligomers, ryanodine receptor-mediated Ca(2+) release, and Wnt-5a/Ca(2+) signaling: opposing roles in neuronal mitochondrial dynamics?Inhibition of cPLA2 activation by Ginkgo biloba extract protects spinal cord neurons from glutamate excitotoxicity and oxidative stress-induced cell death.Cellular prion protein mediates early apoptotic proteome alternation and phospho-modification in human neuroblastoma cells.α-Synuclein-induced synapse damage in cultured neurons is mediated by cholesterol-sensitive activation of cytoplasmic phospholipase A2.Interferon-gamma increases neuronal death in response to amyloid-beta1-42.Impacts of membrane biophysics in Alzheimer's disease: from amyloid precursor protein processing to aβ Peptide-induced membrane changes.Dual role of the p38 MAPK/cPLA2 pathway in the regulation of platelet apoptosis induced by ABT-737 and strong platelet agonists.RhoA/Rho Kinase Mediates Neuronal Death Through Regulating cPLA2 Activation.Human apolipoprotein C-I expression in mice impairs learning and memory functions.

P2860

Q24627548-591FDCD8-3419-4C80-9730-F5B4BB9A89FD Q27340023-ED5BED03-262B-461F-AFE6-7CC01295677F Q28386524-F05B21DF-837E-4E9A-AA8D-1968B6593A9E Q30451918-E1FE8BEE-9048-4DCC-800F-858E44AF1CF9 Q30497694-9D6A5EF2-75DA-4D84-B7D7-A31DC443B7CF Q33554987-8DD123DC-3DA8-40DC-9F4C-34A0A33F14D8 Q33677382-D3882EA9-CC4F-493C-B2DA-920DF092BCEF Q34099708-1FA99DC6-C7EC-44FC-96E1-8A9FFBA73B47 Q34559742-8AB95C11-4FA4-417D-AC01-C69649541B29 Q34679377-D8087606-0C0C-4545-A274-88696228B61B Q35061098-9D1D7821-7383-45D6-8906-04FFF11400A3 Q35067755-F7CAB3B4-A22F-474B-99BB-49391EDC39FB Q35844193-97AF7C93-6897-4A13-8AC5-CAF2D88789DC Q35875480-68E4011A-0EF8-4068-8289-19610DC692D6 Q35886245-6F52BB19-7630-45F1-95CE-BD9975A3FC9A Q35993891-93C629B9-7953-4C5F-8EA1-6AA21107D510 Q36188186-5E600B95-D19B-4218-85A9-43C5B27E3F7C Q36499256-5CF73DC0-63DD-4E0D-AAD5-F1D38772D2CF Q36585560-5C170012-01CF-4FFD-97D1-B536F18FB1E6 Q36925574-54C549EC-0EFF-4DB9-81DD-8B8D2D7B95F1 Q37029870-8553C0A4-A0FD-4088-BF05-6C57C1D0D986 Q37192900-C3110424-7930-4C06-AF16-7B50E9F3AF99 Q37211768-19117E78-08DC-4ECC-83B0-57D321C809FC Q37469703-4DBB5E89-CFB3-4CC7-BB18-2300CFF7EF7A Q37621283-5EEDE0EB-896B-41A7-94B7-0587ECEFEB85 Q37701322-8A533888-2E67-4408-B8B3-7124EE6F6E35 Q38204719-969276E8-E958-433D-ABA6-BD57A685814C Q38635996-1EA79FF5-ECE7-42BB-BDB2-AA0173BA707E Q39374470-0D335DD5-D063-4EF5-96FC-D2A4296BB9A0 Q40395313-B917EC03-4608-4BB0-8E79-282A1A1EAD78 Q41770757-5958FEC9-168C-4236-BD09-6F68935E55BB Q41983079-E282A359-2CAD-4BE2-8491-926C5415D588 Q42060188-8309DCE8-9B5D-4B81-88CC-2AF94F88177A Q42111186-DC5142CE-1842-42B7-8A05-A59D72A56D57 Q42216069-ADB3C70D-5392-469E-B648-3E5905EB7346 Q42726604-AEF99982-E466-4C7E-B3F3-A913AAC7B60A Q42854205-2AB8F5ED-ECBB-4AF6-9198-6D4B337260FF Q48463657-D5BC33CF-F751-4D3F-B00B-FAD1A6FF0352 Q51968405-4285DE9E-B70B-4356-9B75-4469A333C10D

P2860

Cytosolic phospholipase A2 mediates neuronal apoptosis induced by soluble oligomers of the amyloid-beta peptide

http://www.wikidata.org/entity/Q28568454

description

2005 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հունվարին հրատարակված գիտական հոդված

@hy

artikull shkencor

@sq

artículu científicu espublizáu en 2005

@ast

im Januar 2005 veröffentlichter wissenschaftlicher Artikel

@de

scientific journal article

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в січні 2005

@uk

مقالة علمية (نشرت عام 2005)

@ar

name

Cytosolic phospholipase A2 med ...... rs of the amyloid-beta peptide

@ast

Cytosolic phospholipase A2 med ...... rs of the amyloid-beta peptide

@en

Cytosolic phospholipase A2 med ...... rs of the amyloid-beta peptide

@nl

type

label

Cytosolic phospholipase A2 med ...... rs of the amyloid-beta peptide

@ast

Cytosolic phospholipase A2 med ...... rs of the amyloid-beta peptide

@en

Cytosolic phospholipase A2 med ...... rs of the amyloid-beta peptide

@nl

prefLabel

Cytosolic phospholipase A2 med ...... rs of the amyloid-beta peptide

@ast

Cytosolic phospholipase A2 med ...... rs of the amyloid-beta peptide

@en

Cytosolic phospholipase A2 med ...... rs of the amyloid-beta peptide

@nl

P1433

Q28568454-1F62722E-3A58-4F5B-AE22-DA82CD332D02

P1476

Q28568454-255E598F-1700-4077-BFB2-F1F08FD3522B

P2093

Q28568454-014F99E5-6013-46E8-8C11-41891C080F2D

Q28568454-21377BA2-74E0-4619-A898-58530A6366C8

Q28568454-43337AA3-466A-41C8-B84B-6071CC7B46C1

Q28568454-7A27BC24-FE12-49F3-B0AF-C62738F83758

Q28568454-7DAACF1F-10F4-4B91-8E1E-50CFB9067274

Q28568454-87753598-75F1-4F6C-B0A3-D0013F8250A5

Q28568454-8B6B3DF8-DCB2-4C7E-BD75-F43F864F425B

Q28568454-B065F134-CB34-41E3-AFB9-8C0E56256344

Q28568454-C60D8C93-DB4E-4147-8E94-0FC6100A99A7

Q28568454-C6289CB1-083B-4570-8CB4-71B02E5BA4D6

P304

Q28568454-24EFFA9D-0768-4EB8-BC95-32C73A01B2D4

P31

Q28568454-3DB2EE1D-8522-46C1-AF7D-31921EC174FE

P356

Q28568454-E3A5B435-5180-4DF8-9769-5B89CCE9E754

P407

Q28568454-81FA5213-B73A-419C-99FB-931A12D73AD8

P433

Q28568454-9304C4F6-6E5A-4E58-9878-F9B7B2071DE5

P478

Q28568454-6B7AA9FB-163F-4786-BB88-62A2C90616C7

P577

Q28568454-E9F51D6D-6B88-4F4F-8E08-0D7770638D28

P5875

Q28568454-8F602F19-2DF0-484C-BB38-09B8462D3363

P698

Q28568454-CE20AE6A-698B-4B99-9000-0A260D1C784F

P921

Q28568454-D6B2BCB7-F32D-41DC-B950-737D771FC0DA

P356

P1433

P1476

Cytosolic phospholipase A2 med ...... rs of the amyloid-beta peptide

@en

P2093

Alexandre Fifre

http://www.w3.org/2001/XMLSchema#string

Badreddine Kriem

http://www.w3.org/2001/XMLSchema#string

Bernard Bihain

http://www.w3.org/2001/XMLSchema#string

Catherine Malaplate-Armand

http://www.w3.org/2001/XMLSchema#string

Frances T. Yen-Potin

http://www.w3.org/2001/XMLSchema#string

Isabelle Sponne

http://www.w3.org/2001/XMLSchema#string

Jean-Luc Olivier

http://www.w3.org/2001/XMLSchema#string

Karine Lozac'h-Pillot

http://www.w3.org/2001/XMLSchema#string

Thierry Oster

http://www.w3.org/2001/XMLSchema#string

Thierry Pillot

http://www.w3.org/2001/XMLSchema#string

P304

85–87

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1096/FJ.04-1807FJE

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P577

2005-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8230758

http://www.w3.org/2001/XMLSchema#string

P698

15486059

http://www.w3.org/2001/XMLSchema#string

P921

apoptotic process